Introduction
Surveys are an indispensable tool for assessing the impact of clinical research on patients and medical professionals alike. ESICM endorsement is a guarantee of quality survey design and rigorous methodology. Do you have a survey you would like ESICM to endorse? For researchers seeking ESICM survey endorsement, please prepare the following documents for submission: Tools and questionnaires for applicants – ESICM Survey Application Form.
Learn more about the completed surveys here.
For any questions, please contact research [ @ ] esicm.org
The Overall Aim: To explore on the global variations in clinical practice regarding regional citrate anticoagulation in continuous renal replacement therapy (RCA-CRRT).
The Primary Objective: To describe differences in clinical practices and protocols for the management of RCA-CRRT.Secondary Objectives:
To describe various monitoring protocols in relation to geographical location (country) and institutional experience; To describe the prescription of RCA-CRRT in cases of relative contraindication, stratified by institutional experience; To evaluate the relationship between protocol availability and nursing confidence in the monitoring and management of RCA-CRRT.
Steering Committee: Prof Salvatore Lucio Cutuli, Catholic University of the Sacred Heart, Rome (IT).
Ilona Lemagnen, CHUV, Lausanne (CH). Beatrice Brunoni, CHUV, Lausanne (CH). Xiaopu Hou, CHUV, Lausanne (CH) / Sengkang General Hospital (SG). Rita Jacob, Universitair Ziekenhuis Antwerpen, (BE).
Contact: Prof Antoine Schneider, CHUV, Lausanne (CH). Prof Eric Hoste, Ghent University Hospital, Ghent, (BE). Prof Thomas Rimmelé, Nice University Hospital, Nice (FR). Swee Ping TEH, CHUV, Lausanne, Switzerland / Sengkang General Hospital (SG) sweepmd [ @ ] gmail.com
The target population is restricted to physicians (intensivists or nephrologists) and nurses actively managing Continuous Renal Replacement Therapy (CRRT) within the Intensive Care Unit (ICU). The survey takes less than 12 minutes to complete.
Complete the survey here.
The primary objective of this study is to identify the clinical, imaging, and neuromonitoring factors that prompt clinicians to perform cerebral angiography for the diagnosis and possible treatment of delayed cerebral ischemia (DCI) and cerebral vasospasm in patients with aneurysmal subarachnoid haemorrhage (aSAH). The NIC Section has approved the survey.
Steering Committee: Gabriel Torrealba-Acosta, Cherylee Chang, Daniel Laskowitz, Michael Luke James, Cina Sasannejad.
Contact: Dr. Gabriel Torrealba-Acosta, Duke University Hospital, Dept. of Neurology, Durham, NC, USA: gabriel.torrealba-acosta [ @ ] duke.edu
The target population includes board-certified or board-eligible neurointensivists, neurocritical care and critical care fellows, and advanced practice providers (APPs) who are actively involved in the care of aSAH patients. The survey takes around 10-12 minutes to complete.
Complete the survey here.
This survey seeks to collect data on the current practices, challenges, and decision-making processes of ICU professionals regarding rehabilitation strategies during weaning from mechanical ventilation. This survey aims to complement and build upon the findings of the global observational study WEAN SAFE. While WEAN SAFE has provided valuable insights into the general practices and outcomes associated with weaning from mechanical ventilation, our survey will specifically focus on the role of rehabilitation during this critical phase. The ARF Section has approved the survey.
Steering Committee: Denise Battaglini, Sergio Lassola, Rik Gosselink, Markus Haar, Kevin Roedl, Silvia De Rosa, Lise Piquilloud, Leo Heunks, Carol Hodgson, Laura Buiteman-Kruizinga, Tobias D van Leijsen, Marcus J. Schultz.
Contact: Denise Battaglini, Dept. of Surgical Sciences & Integrated Diagnostics, University of Genoa, Genoa, Italy: battaglini.denise [ @ ] gmail.com or denise.battaglini [ @ ] unige.it
This survey is intended for healthcare professionals who work in the ICU. This includes a multidisciplinary group of physicians at various levels of responsibility and expertise, such as medical directors, physiotherapists, senior physicians, attending consultants, nurses and assistant physicians. The survey takes around 20 minutes each to complete.
Complete the survey here.
We invite all ICU nurses to take part in the 1st Round of the SHINE-Delphi Study:
Shaping ICU Nurses’ Future — How ICU Nurses Envision the Professional Role in 2030 and Beyond (SHINE)
The SHINE study aims to explore ICU nurses’ visions for their evolving roles over the next decade, providing insights to guide future workforce planning, policy development, and education in intensive care. Building a patient centred, technology enabled, and human focused ICU starts with your voice. The study has received ethical approval from King’s College, UK (MRA-24/25-48726).
Steering Committee: Carole Boulanger, Prof Ruth Kleinpell, Dr Peter Nydahl, Dr Julia Philippou, Dr Brandi Vanderspank-Wright, Dr Andreas Xyrichis, Prof Mark van den Boogaard.
Contact: Lead researcher Dr Katerina Iliopoulou, RN. Past-Chair N&AHPs, ESICM.
[Katerina.Iliopoulou@citystgeorges.ac.uk]
Who can participate?
All ICU nurses currently working in intensive care, in any country and any type of ICU.
Incentive for participation:
ICU nurses who complete all three Delphi rounds will be entered into a lottery for 12 free registration places for ESICM’s, LIVE, 2026 in Lisbon, Portugal.
The questionnaire is available in nine languages. Please select the language you wish to use to complete the 1st round of SHINE questionnaire: Please complete Round 1 by 6 May 2026 at 12:00 pm CET.
Complete the survey here.
This survey aims to help better understand anticoagulation practices in adult patients receiving ECMO support. This survey focuses on anticoagulation in V-V ECMO and ECPR adult patients only. This ESICM-endorsed survey is an initiative of the EuroELSO Working Group on Coagulation, Antithrombotics and Patient Blood Management.
Steering Committee: Annemiek Oude Lansing, Nick Barrett, Nina Buchtele, Mauro Panigada, Sasa Rajsic, Jordi Riera, Christoph van den Briele.
Contact: Annemiek Oude Lansing, UMCG – University Medical Center Groningen, Netherlands. a.oudelansink [ @ ] umcg.nl
This survey targets physiciansHealthcare Professionals focusing on focusing on V‑V ECMO patients, ECPR, or both pathways. Adults and paediatrics. The survey should take no longer than 10 minutes to complete.
Complete the survey here.
The primary objective of this survey is to assess the level of awareness, understanding, and perceived relevance of translational medicine within the European Society of Intensive Care Medicine (ESICM) community. Specifically, the survey aims to explore how ESICM members conceptualise translational research and its role in intensive care. The purpose of this survey is to explore the knowledge, attitudes, and clinical practices of medical doctors and pharmacists regarding the pharmacological management of anaemia in critically ill patients. By identifying current clinical perspectives and practices, this survey aims to clearly identify barriers to implementation and contribute to the development of more effective and evidence-informed anaemia management strategies in the ICU setting. This survey has been approved by the Pharmacology and Pharmacotherapy section, the Anaesthesia and Perioperative Medicine section, and the ESICM Transfusion Task Force.
Steering Committee: Shodai Yoshihiro, Mitsuaki Nishikimi, Yuki Kataoka, Richard S. Bourne, Cathrine McKenzie, Kent Doi, Simon Oczkowski, Joanna Dionne, Alexander P.J. Vlaar, Nobuaki Shime, and Hiroaki Matsuo.
Contact: Shodai Yoshihiro, Dept. of Pharmaceutical Services, Hiroshima University Hospital, Hiroshima, Japan. shodaidotnet [ @ ] gmail.com
This survey targets physicians and pharmacists who are currently or have previously worked in the ICU. Approximately 15 minutes are required to complete the questionnaire.
Complete the survey here.
The primary objective of this survey is to assess the level of awareness, understanding, and perceived relevance of translational medicine within the European Society of Intensive Care Medicine (ESICM) community. Specifically, the survey aims to explore how ESICM members conceptualise translational research and its role in intensive care. This survey is an initiative of the TransBio Section.
Steering Committee: Miklos Lipcsey, Burcin Halacli, Gaetanno Perchiazzi, John Laffey, Luis Morales, Elena Sancho Ferrando, Marta Camprubi Rimblas.
Contact: Burcin Halacli, Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Ankara, Turkey, burcin.halacli [ @ ] yahoo.com
This survey targets physicians, nurses and allied health professionals (N&AHPs), fellows, PhD students, and researchers with an interest in intensive care and critical illness. The participation is anonymous, and no identifiable personal data will be collected. The survey should take no longer than 4 minutes to complete.
Complete the survey here.
The primary objective is to describe current practices in the management of new-onset atrial fibrillation (AF) in ICU patients across Worldwide intensive care units. As secondary objectives, there are to identify criteria used to initiate treatment (rate vs. rhythm control); to assess variability in treatment strategies depending on clinical context (sepsis, shock, postoperative period, etc.); to evaluate the use of anticoagulation in critically ill patients with new-onset AF; to explore potential barriers to guideline implementation; and to provide data that can inform future prospective studies and harmonize management across centres. This survey has been endorsed by the ESICM CD Section.
Steering Committee: Michelle Chew, Daniel De Backer, Ricard Ferrer, Olfa Hamzaoui, Vincent Labbe, Guillaume Thery | Lead: Olfa Hamzaoui, Intensive care unit, University Hospitals of Reims, France.
Contact: Guillaume Thery, Intensive care unit, University Hospitals of Reims, Christian Cabrol Hospital, Rue du Général Koenig, 51100 Reims, France. gthery@chu-reims.fr
This is a cross-sectional, questionnaire-based survey. The target population includes intensivists and ICU physicians involved in the management of critically ill patients. All ICU patients with new-onset atrial fibrillation (AF) during their ICU stay are the clinical scenario of interest. The survey is anonymous.
Please answer the questions in the order they are presented. There are 81 questions, and it takes about 15 minutes to complete them.
Complete the survey here.
